|
|
||||||||
a The John Hopkins Medical Institutions, Baltimore, Maryland
b The University of Washington, Seattle
c The University of Pittsburgh, Pennsylvania
d The University of California at Davis, Sacramento
e St. Francis Hospital, Roslyn, New York
f The University of California at Los Angeles
g The University of Vermont, Burlington
h Uniformed Services University of the Health Sciences, Bethesda, Maryland
i Wake Forest University School of Medicine, Winston-Salem, North Carolina
Linda P. Fried, Director, Center on Aging and Health, The Johns Hopkins Medical Institutions, 2024 East Monument Street, Suite 2-700, Baltimore, MD 21205 E-mail: lfried{at}welch.jhu.edu.
Decision Editor: John E. Morley, MB, BCh
Background. Frailty is considered highly prevalent in old age and to confer high risk for falls, disability, hospitalization, and mortality. Frailty has been considered synonymous with disability, comorbidity, and other characteristics, but it is recognized that it may have a biologic basis and be a distinct clinical syndrome. A standardized definition has not yet been established.
Methods. To develop and operationalize a phenotype of frailty in older adults and assess concurrent and predictive validity, the study used data from the Cardiovascular Health Study. Participants were 5,317 men and women 65 years and older (4,735 from an original cohort recruited in 198990 and 582 from an African American cohort recruited in 199293). Both cohorts received almost identical baseline evaluations and 7 and 4 years of follow-up, respectively, with annual examinations and surveillance for outcomes including incident disease, hospitalization, falls, disability, and mortality.
Results. Frailty was defined as a clinical syndrome in which three or more of the following criteria were present: unintentional weight loss (10 lbs in past year), self-reported exhaustion, weakness (grip strength), slow walking speed, and low physical activity. The overall prevalence of frailty in this community-dwelling population was 6.9%; it increased with age and was greater in women than men. Four-year incidence was 7.2%. Frailty was associated with being African American, having lower education and income, poorer health, and having higher rates of comorbid chronic diseases and disability. There was overlap, but not concordance, in the cooccurrence of frailty, comorbidity, and disability. This frailty phenotype was independently predictive (over 3 years) of incident falls, worsening mobility or ADL disability, hospitalization, and death, with hazard ratios ranging from 1.82 to 4.46, unadjusted, and 1.292.24, adjusted for a number of health, disease, and social characteristics predictive of 5-year mortality. Intermediate frailty status, as indicated by the presence of one or two criteria, showed intermediate risk of these outcomes as well as increased risk of becoming frail over 34 years of follow-up (odds ratios for incident frailty = 4.51 unadjusted and 2.63 adjusted for covariates, compared to those with no frailty criteria at baseline).
Conclusions. This study provides a potential standardized definition for frailty in community-dwelling older adults and offers concurrent and predictive validity for the definition. It also finds that there is an intermediate stage identifying those at high risk of frailty. Finally, it provides evidence that frailty is not synonymous with either comorbidity or disability, but comorbidity is an etiologic risk factor for, and disability is an outcome of, frailty. This provides a potential basis for clinical assessment for those who are frail or at risk, and for future research to develop interventions for frailty based on a standardized ascertainment of frailty.
This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)
|
L. M. Kern, N. R. Powe, M. A. Levine, A. L. Fitzpatrick, T. B. Harris, J. Robbins, and L. P. Fried Association between Screening for Osteoporosis and the Incidence of Hip Fracture Ann Intern Med, February 1, 2005; 142(3): 173 - 181. [Abstract] [Full Text] [PDF] |
||||
|
J. F. Wilson Frailty--and Its Dangerous Effects--Might Be Preventable Ann Intern Med, September 21, 2004; 141(6): 489 - 492. [Full Text] [PDF] |
||||
|
A. Mitnitski and K. Rockwood Help Available--Phenomenological Models for Research on Aging Sci. Aging Knowl. Environ., March 26, 2003; 2003(12): vp2 - 2. [Abstract] [Full Text] |
||||
|
J. E. Morley and J. H. Flaherty Editorial It's Never Too Late: Health Promotion and Illness Prevention in Older Persons J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2002; 57(6): M338 - 342. [Full Text] |
||||
|
W. M. Bortz II A Conceptual Framework of Frailty: A Review J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2002; 57(5): M283 - 288. [Abstract] [Full Text] |
||||
|
A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text] |
||||
|
J. E. Morley Editorial: Drugs, Aging, and the Future J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2002; 57(1): M2 - 6. [Full Text] [PDF] |
||||
|
J. E. Morley Editorial: Andropause: Is It Time for the Geriatrician to Treat It? J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2001; 56(5): 263M - 265. [Full Text] |
||||
|
M. Gillick Guest Editorial: Pinning Down Frailty J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2001; 56(3): 134M - 135. [Full Text] |
||||
|
A. B. Newman, J. S. Gottdiener, M. A. McBurnie, C. H. Hirsch, W. J. Kop, R. Tracy, J. D. Walston, and L. P. Fried Associations of Subclinical Cardiovascular Disease With Frailty J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2001; 56(3): 158M - 166. [Abstract] [Full Text] |
||||
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
---|
All GSA journals | The Gerontologist |
Journals of Gerontology Series B: Psychological Sciences and Social Sciences |